1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Urinary Tract Infection Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class, Indication, Distribution Channel, and Geography

Urinary Tract Infection Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class, Indication, Distribution Channel, and Geography

  • November 2020
  • 241 pages
  • ID: 6010111
  • Format: PDF
  • The Insight Partners
Up to $1700 off Until May 20th 2021


Table of Contents

Search Inside

The market is expected to reach US$ 11,614.32 million in 2027 from US$ 9,106.40 million in 2019. The market is estimated to grow with a CAGR of 3.2% from 2020-2027. The growth of the market is attributed to some key driving factors such as growing prevalence of urinary tract infections, aging population and emerging computing technologies for urine diagnostics. However, lack of product awareness in emerging countries along with associated effects of medication is expected to obstruct the growth of the market to a certain extent during the forecast years.
Urinary tract infection (UTI) is an infection of the lower or upper urinary tract and occurs due to colonization of microbial pathogens in bladder or kidneys.The common symptoms of UTI are pain with urination, high frequency of urination, and urge of urination despite having an empty bladder.

UTI is more common among women than men as their urethra is comparatively smaller. There are two types of urinary tract infections: complicated urinary tract infection and uncomplicated urinary tract infection.
Emerging technologies such as remote patient monitoring, artificial intelligence (AI), mobile technologies, and natural language processing are expected to enhance the efficiency of diagnostic procedures.A majority of the industry players focus on the development and distribution of advanced kits and equipment with an aim to improvise the process of home diagnostics.

For instance, in May 2019, Scanwell Health launched an at-home smartphone-enabled test and treatment service for UTIs in the US. This is now available in all 50 states.
Novartis Venture Fund and Hikma Ventures in collaboration with Lemonaid Health, a telehealth company developed an easy application to get care for conditions like acid reflux, erectile dysfunction, flu, hair loss, urinary tract infections (UTIs) and for birth control medication. Moreover, the company has raised ~US$ 3.5 million to develop technologically advanced UTI diagnostics. Furthermore, in July 2019, Tel-Aviv, an Israel-based AI start-up announced the launch of its technology-enabled Dip UTI test kits in the UK. Emerging technologies for accurate and timely diagnosis would increase the number of diagnosed cases and help treat patients effectively, thereby driving the urinary tract infection treatment market.
Based on drug class, the quinolones segment held the largest share of the market in 2019; however, the penicillin and combination segment is anticipated to register the highest CAGR of 4.5% in the market during the forecast period. Quinolones drug class segment is expected to show robust growth over forecast period as the physicians most commonly prescribe it. Ciprofloxacin, levofloxacin, and enoxacin are among the most widely used drugs for treatment.
The COVID-19 pandemic was first reported in December 2019 in Wuhan (China).The impacts of this outbreak are being felt across several markets in the world.

The demand for urinary tract infection treatment solutions has reduced amid this global crisis due to a significant shift in the focus toward the management, treatment, and prevention of COVID-19. The pandemic continues to worsen, causing massive disruptions in the global supply chains, consumer markets, and economies, and these conditions are also restraining the growth of the urinary tract infection treatment market.
The Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Union (EU), Organization for Economic Co-operation and Development, Southern Africa Development Community, American Academy of Dermatology Association, US Food and Drug Administration (FDA), and National Health Service (NHS) are a few of the prime secondary sources referred to while preparing this report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Cancer Cachexia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • $ 4250
  • March 2021
  • 154 pages

The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak ...

  • World
  • Europe
  • Therapy
  • Industry analysis
  • Cancer Incidence
  • Cancer Mortality


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on